Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms.
Aged
Carcinoma, Pancreatic Ductal
/ surgery
Female
Follow-Up Studies
Humans
Male
Middle Aged
Nutritional Status
Pancreatic Cyst
/ surgery
Pancreatic Neoplasms
/ surgery
Pancreaticoduodenectomy
/ adverse effects
Patient Reported Outcome Measures
Postoperative Complications
/ epidemiology
Prospective Studies
Quality of Life
Treatment Outcome
Benign pancreatic cystic lesions
Exocrine and endocrine insufficiency
Long-term functional outcomes
Pancreatic resection
Quality of life
Journal
The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
24
05
2019
revised:
20
08
2019
accepted:
19
09
2019
pubmed:
20
11
2019
medline:
11
6
2020
entrez:
20
11
2019
Statut:
ppublish
Résumé
With advances in cross-sectional imaging, pancreatic cysts are more frequently diagnosed and have become a common indication for pancreatectomy. The impact of pancreatectomy in these patients is important. The purpose of this study was to assess short-term outcomes, long-term nutritional status, quality of life (QOL), and pancreas function after pancreatectomy for cystic neoplasms. At a single institution, patients at least 3 y post-pancreatectomy for benign cystic neoplasms were identified. Using a validated questionnaire, short-term outcomes, long-term outcomes including endocrine and exocrine insufficiency, long-term nutritional status, and preoperative and postoperative QOL were compared based on operation and indication for resection. Among 102 eligible patients, 70 had valid contact information and 51 (72.9%) agreed to participate. Median follow-up was 6 (4-8) y. Patients undergoing pancreatoduodenectomy for benign cysts had higher morbidity than a similar cohort resected for pancreatic adenocarcinoma (patients with at least 1 ≥ grade 2 complication [49.0% versus 31.6%, P = 0.038]). After long-term follow-up, pancreatectomy did not significantly affect perceived QOL. Half of patients had mild-moderate or severe malnourishment, but pancreatic enzyme replacement was reported by only 4 (7.8%) patients. New-onset diabetes was present in 15 (29.4%) patients with median time-to-diagnosis of 6 (1-12) mo after resection. Pancreatectomy for benign cysts did not negatively impact patients' perceived QOL. However, after long-term follow-up, malnutrition and pancreatic insufficiency occurred in a significant percentage and may be greater than previously estimated. Consideration of short- and long-term outcomes should factor into preoperative counseling, especially in cysts with minimal risk of progression to malignancy.
Sections du résumé
BACKGROUND
With advances in cross-sectional imaging, pancreatic cysts are more frequently diagnosed and have become a common indication for pancreatectomy. The impact of pancreatectomy in these patients is important. The purpose of this study was to assess short-term outcomes, long-term nutritional status, quality of life (QOL), and pancreas function after pancreatectomy for cystic neoplasms.
MATERIALS AND METHODS
At a single institution, patients at least 3 y post-pancreatectomy for benign cystic neoplasms were identified. Using a validated questionnaire, short-term outcomes, long-term outcomes including endocrine and exocrine insufficiency, long-term nutritional status, and preoperative and postoperative QOL were compared based on operation and indication for resection.
RESULTS
Among 102 eligible patients, 70 had valid contact information and 51 (72.9%) agreed to participate. Median follow-up was 6 (4-8) y. Patients undergoing pancreatoduodenectomy for benign cysts had higher morbidity than a similar cohort resected for pancreatic adenocarcinoma (patients with at least 1 ≥ grade 2 complication [49.0% versus 31.6%, P = 0.038]). After long-term follow-up, pancreatectomy did not significantly affect perceived QOL. Half of patients had mild-moderate or severe malnourishment, but pancreatic enzyme replacement was reported by only 4 (7.8%) patients. New-onset diabetes was present in 15 (29.4%) patients with median time-to-diagnosis of 6 (1-12) mo after resection.
CONCLUSIONS
Pancreatectomy for benign cysts did not negatively impact patients' perceived QOL. However, after long-term follow-up, malnutrition and pancreatic insufficiency occurred in a significant percentage and may be greater than previously estimated. Consideration of short- and long-term outcomes should factor into preoperative counseling, especially in cysts with minimal risk of progression to malignancy.
Identifiants
pubmed: 31740011
pii: S0022-4804(19)30690-0
doi: 10.1016/j.jss.2019.09.045
pmc: PMC8094044
mid: NIHMS1688990
pii:
doi:
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
547-555Subventions
Organisme : NHLBI NIH HHS
ID : T32 HL139425
Pays : United States
Informations de copyright
Copyright © 2019. Published by Elsevier Inc.
Références
Pancreatology. 2017 Sep - Oct;17(5):738-753
pubmed: 28735806
Pancreas. 2014 Jul;43(5):755-61
pubmed: 24743379
HPB (Oxford). 2010 Sep;12(7):472-81
pubmed: 20815856
Pancreas. 2011 Nov;40(8):1258-63
pubmed: 21705943
J Am Coll Surg. 2015 Jun;220(6):1087-95
pubmed: 25868415
Pancreatology. 2017 Nov - Dec;17(6):974-982
pubmed: 28958898
Pancreas. 2016 Aug;45(7):986-91
pubmed: 26692445
Surgery. 2018 Nov;164(5):1035-1048
pubmed: 30029989
Ann Surg. 2006 May;243(5):673-80; discussion 680-3
pubmed: 16633003
Dig Dis Sci. 2017 Mar;62(3):626-632
pubmed: 28116593
AJR Am J Roentgenol. 2008 Sep;191(3):802-7
pubmed: 18716113
Ann Surg. 2017 Oct;266(4):685-692
pubmed: 28657944
Med Care. 2009 Aug;47(8):866-74
pubmed: 19584761
Ann Surg. 2009 Aug;250(2):177-86
pubmed: 19638919
Ann Surg. 2013 Dec;258(6):930-42
pubmed: 23732268
Nutr Clin Pract. 2008 Aug-Sep;23(4):405-9
pubmed: 18682592
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Pancreatology. 2014 Mar-Apr;14(2):131-6
pubmed: 24650968
Surgery. 2007 Nov;142(5):761-8
pubmed: 17981197
J Surg Oncol. 2017 Feb;115(2):144-150
pubmed: 27859270
Ann Surg. 2000 Jun;231(6):890-8
pubmed: 10816633
Isr Med Assoc J. 2011 May;13(5):284-9
pubmed: 21845969
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
Pancreatology. 2009;9(6):729-37
pubmed: 20090394
JMIR Ment Health. 2017 Sep 26;4(3):e37
pubmed: 28951382
J Clin Oncol. 2002 May 1;20(9):2229-39
pubmed: 11980994
Br J Surg. 2008 Jan;95(1):85-91
pubmed: 18041022
J Gastrointest Surg. 2014 Jan;18(1):172-79; discussion 179-80
pubmed: 24002771
Ann Surg. 2018 Feb;267(2):259-270
pubmed: 28834847
Surg Infect (Larchmt). 2015 Dec;16(6):657-68
pubmed: 26244748
J Surg Oncol. 2013 Jan;107(1):97-103
pubmed: 22991309
Int J Surg. 2011;9(8):655-8
pubmed: 21925294
Pancreatology. 2012 May-Jun;12(3):183-97
pubmed: 22687371
BMC Surg. 2015 Oct 30;15:120
pubmed: 26518473
Nutrients. 2017 Mar 07;9(3):
pubmed: 28272344
J Am Coll Surg. 2013 Jan;216(1):1-14
pubmed: 23122535
Br J Surg. 2016 Feb;103(3):257-66
pubmed: 26785646
Pancreatology. 2006;6(1-2):17-32
pubmed: 16327281